StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$103.32+1.23 (+1.20%)

Close on Nov 18, 2026Market cap $19.71BP/E 25.1Yield 0.93%

Zimmer Biomet operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Zimmer Biomet's operating income for the twelve months ending Jun 30, 2026 was $1.21B, down 4.4% year over year. For fiscal 2025 it was $1.10B, down 14.6% from the year before. Over ten years it grew 8.9% a year on average. The highest annual figure on record is $1.29B in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.10B-14.6%
FY2024Dec 31, 2024$1.29B+0.6%
FY2023Dec 31, 2023$1.28B+83.5%
FY2022Dec 31, 2022$696.30M-19.1%
FY2021Dec 31, 2021$860.30M+935.3%
FY2020Dec 31, 2020$83.10M-92.7%
FY2019Dec 31, 2019$1.14B+3265.4%
FY2018Dec 31, 2018$33.80M-95.8%
FY2017Dec 31, 2017$799.30M-2.7%
FY2016Dec 31, 2016$821.10M+75.7%
FY2015Dec 31, 2015$467.30M-55.0%
FY2014Dec 31, 2014$1.04B-2.9%
FY2013Dec 31, 2013$1.07B+2.0%
FY2012Dec 31, 2012$1.05B+2.3%
FY2011Dec 31, 2011$1.02B+11.7%
FY2010Dec 31, 2010$916.70M-10.0%
FY2009Dec 31, 2009$1.02B-6.5%
FY2008Dec 31, 2008$1.09B-3.3%
FY2007Dec 31, 2007$1.13B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$326.10M+8.7%
Q1 FY2026Mar 31, 2026$373.20M+27.7%
Q4 FY2025Dec 31, 2025$154.50M-60.3%
Q3 FY2025Sep 30, 2025$351.30M+25.7%
Q2 FY2025Jun 30, 2025$300.00M-14.6%
Q1 FY2025Mar 31, 2025$292.30M+9.9%
Q4 FY2024Dec 31, 2024$389.00M+9.8%
Q3 FY2024Sep 30, 2024$279.50M+4.8%
Q2 FY2024Jun 30, 2024$351.30M+6.6%
Q1 FY2024Mar 31, 2024$265.90M-18.8%
Q4 FY2023Dec 31, 2023$354.20M–
Q3 FY2023Sep 30, 2023$266.60M+8.7%
Q2 FY2023Jun 30, 2023$329.60M+17.3%
Q1 FY2023Mar 31, 2023$327.30M+65.0%
Q4 FY2022Dec 31, 2022-$28.30M-121.2%
Q3 FY2022Sep 30, 2022$245.30M+0.9%
Q2 FY2022Jun 30, 2022$280.90M+25.0%
Q1 FY2022Mar 31, 2022$198.40M-23.3%
Q4 FY2021Dec 31, 2021$133.80M-67.5%
Q3 FY2021Sep 30, 2021$243.00M-18.8%
Q2 FY2021Jun 30, 2021$224.80M–
Q1 FY2021Mar 31, 2021$258.70M–
Q4 FY2020Dec 31, 2020$411.60M+22.2%
Q3 FY2020Sep 30, 2020$299.20M+21.7%
Q2 FY2020Jun 30, 2020-$171.70M-183.9%
Q1 FY2020Mar 31, 2020-$456.00M-230.2%
Q4 FY2019Dec 31, 2019$336.80M–
Q3 FY2019Sep 30, 2019$245.80M+10.1%
Q2 FY2019Jun 30, 2019$204.70M-30.8%
Q1 FY2019Mar 31, 2019$350.20M+14.8%
Q4 FY2018Dec 31, 2018-$790.50M–
Q3 FY2018Sep 30, 2018$223.30M+5.7%
Q2 FY2018Jun 30, 2018$296.00M+5.7%
Q1 FY2018Mar 31, 2018$305.00M-12.4%
Q4 FY2017Dec 31, 2017-$40.10M-122.5%
Q3 FY2017Sep 30, 2017$211.20M+8.0%
Q2 FY2017Jun 30, 2017$280.10M–
Q1 FY2017Mar 31, 2017$348.10M–
Q4 FY2016Dec 31, 2016$178.50M–
Q3 FY2016Sep 30, 2016$195.50M–

More Zimmer Biomet figures

See a number that looks wrong?